Healthcare

Senators say EpiPen overcharged Pentagon

By Robert King
Published November 7, 2016 7:50pm ET
Add Washington Examiner on Google
Senators say EpiPen overcharged Pentagon
Mylan misclassified the allergy drug, which led the Defense Department to pay "exorbitant rates," lawmakers say. (AP Photo/Pablo Martinez Monsivais, File) | Pablo Martinez Monsivais

A trio of bipartisan senators want drug maker Mylan to pay back the Department of Defense for overcharging for the allergy drug EpiPen.

The senators said Mylan misclassified the EpiPen that “led the DoD to pay exorbitant rates for the drug at retail pharmacies,” according to a letter sent to Mylan CEO Heather Bresch on Monday. The company has seen outrage from Congress for price hikes for the life-saving drug, which now costs $600 for a two-pack.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Amy Klobuchar Chuck Grassley Department of Justice Epipen Minusextra Pentagon Richard Blumenthal Robert King